Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0273 | 0.2082 | 0.2761 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0418 | 0.4247 | 0.5717 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0633 | 0.7428 | 1 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0446 | 0.4654 | 0.6265 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0403 | 0.4022 | 0.3985 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0446 | 0.4654 | 0.6265 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0633 | 0.7428 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0419 | 0.4255 | 0.5728 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0446 | 0.4654 | 0.6243 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0419 | 0.4255 | 0.5704 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0418 | 0.4247 | 0.5717 |
Mycobacterium ulcerans | polyketide synthase | 0.0446 | 0.4654 | 0.6265 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0419 | 0.4255 | 0.5728 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0419 | 0.4255 | 0.5728 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0778 | 0.9593 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0419 | 0.4255 | 0.5728 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0175 | 0.0622 | 0.0837 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0335 | 0.3002 | 0.4006 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0136 | 0.0045 | 0.006 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0273 | 0.2082 | 0.2803 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0245 | 0.1675 | 0.2255 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0419 | 0.4255 | 0.5704 |
Mycobacterium ulcerans | thioesterase | 0.036 | 0.3374 | 0.4542 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0335 | 0.3002 | 0.4041 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0273 | 0.2082 | 0.2803 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0633 | 0.7428 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0335 | 0.3002 | 0.4041 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0307 | 0.2594 | 0.3914 |
Mycobacterium ulcerans | thioesterase TesA | 0.036 | 0.3374 | 0.4542 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.034 | 0.3086 | 0.4154 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0446 | 0.4654 | 0.6265 |
Brugia malayi | AMP-binding enzyme family protein | 0.0403 | 0.4022 | 0.4022 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0419 | 0.4255 | 0.4255 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0446 | 0.4654 | 0.6243 |
Loa Loa (eye worm) | hypothetical protein | 0.0229 | 0.1434 | 0.0597 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0446 | 0.4654 | 0.6265 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.028 | 0.2189 | 0.2718 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0633 | 0.7428 | 1 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0403 | 0.4022 | 0.5414 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0446 | 0.4654 | 0.6243 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0419 | 0.4255 | 0.5728 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0136 | 0.0043 | 0.0058 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0419 | 0.4255 | 0.5728 |
Loa Loa (eye worm) | hypothetical protein | 0.0713 | 0.8617 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0446 | 0.4654 | 0.6265 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0136 | 0.0043 | 0.0058 |
Onchocerca volvulus | 0.0751 | 0.9194 | 0.9285 | |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.031 | 0.2636 | 0.3549 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.036 | 0.3374 | 0.4542 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0446 | 0.4654 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0419 | 0.4255 | 0.5728 |
Loa Loa (eye worm) | fatty acid synthase | 0.0426 | 0.4358 | 0.4425 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.036 | 0.3374 | 0.451 |
Mycobacterium ulcerans | polyketide synthase | 0.0419 | 0.4255 | 0.5728 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 160 uM | PUBCHEM_BIOASSAY: Fluorescence Cell-Based Secondary Assay to Identify Inhibitors of Resistant C. albicans Growth in the Presence of Fluconazole. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1979, AID2007] | ChEMBL. | No reference |
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488991] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.